Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic interactions of omeprazole + daclatasvir in volunteers

Trial Profile

Pharmacokinetic interactions of omeprazole + daclatasvir in volunteers

Phase of Trial: Phase I

Latest Information Update: 06 May 2013

At a glance

  • Drugs Daclatasvir (Primary) ; Omeprazole
  • Indications Duodenal ulcer; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; Hepatitis C; Peptic ulcer; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 May 2013 New trial record
    • 28 Apr 2013 Results presented at the 48th Annual Meeting of the European Association for the Study of the Liver.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top